# Forcyte Biotechnologies, Inc. — Form D

Forcyte Biotechnologies, Inc. of LOS ANGELES, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-01-10. The offering totals $2.0M, of which $1.0M was reported sold. Industry: Other Technology.

## Offering

- Filed: 2019-01-10
- Form: D
- Accession: 0001760069-19-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $1.0M
- Remaining: $1.0M
- Minimum investment: $25K
- Investors: 3
- Date of first sale: 2018-12-18
- Revenue range: No Revenues
- SEC file number: 021-330118

## Issuer

- Name: Forcyte Biotechnologies, Inc.
- CIK: 0001760069
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 11957 DARLINGTON AVENUE, LOS ANGELES, CA, 90049
- Phone: 8594204398

## Officers, directors & promoters (1)

| Name | Role | Location |
| --- | --- | --- |
| Ivan Pushkarsky | Executive Officer | Los Angeles, CA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2019-01-15](https://search.stillhousedata.com/formd/0001760069-19-000002) | D/A | $2.0M | $160K |

## More

- [CIK 1760069 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1760069&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001760069-19-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.